Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 31, 2021
Synthesis and Preclinical Evaluation of a 68Ga-Labeled Adnectin, 68Ga-BMS-986192, as a PET Agent for Imaging PD-L1 ExpressionStephanie Robu, Antonia Richter, Dario Gosmann, et al.Prostate Cancer and Prostatic Diseases|February 12, 2025
Is there a role of PSMA-PET in focal therapy planning and follow-up?Rossella Nicoletti, Andrea Alberti, Vineet Gauhar, et al.Urologic Oncology|August 1, 2021
How to manage patients with suspected upper tract urothelial carcinoma in the pandemic of COVID-19?Hsiang-Ying Lee, Erica On-Ting Chan, Ching-Chia Li, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 16, 2020
Quantification of PD-L1 Expression with 18F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung CancerMarc C Huisman, Anna-Larissa N Niemeijer, Albert D Windhorst, et al.Neuro-Oncology|November 1, 2020
Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trialsBenjamin M Ellingson, Matthew S Brown, Jerrold L Boxerman, et al.JAMA Network Open|November 12, 2025
Trastuzumab Deruxtecan for ERBB2-Mutant Metastatic Non-Small Cell Lung Cancer With or Without Brain Metastases: A Secondary Analysis of Randomized Clinical TrialsPasi A Jänne, David Planchard, Koichi Goto, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 ExpressionDavid J Donnelly, R Adam Smith, Paul Morin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204Raymond Y Huang, Gilbert Youssef, Thomas Nelson, et al.European Urology Oncology|January 7, 2024
The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort StudyDavid Leung, Daniele Castellani, Rossella Nicoletti, et al.Neuro-Oncology|May 5, 2022
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoterMichael Lim, Michael Weller, Ahmed Idbaih, et al.Pageof 4